These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2655160)

  • 1. A study on the properties of commercial thrombin preparations.
    Suzuki S; Sakuragawa N
    Thromb Res; 1989 Feb; 53(3):271-7. PubMed ID: 2655160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impurity of thrombin preparations for clinical use.
    Ueshima S; Yamamoto T; Okada K; Sakai T; Matsuo O
    J Clin Hosp Pharm; 1985 Jun; 10(2):193-202. PubMed ID: 4019792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative purity of different bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Iqbal O; Litinas E; Adiguzel C; Fareed J
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):681-8. PubMed ID: 19850589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative purity of thrombin-based hemostatic agents used in surgery.
    Schoenecker JG; Johnson RK; Fields RC; Lesher AP; Domzalski T; Baig K; Lawson JH; Parker W
    J Am Coll Surg; 2003 Oct; 197(4):580-90. PubMed ID: 14522327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulant versus amidolytic properties of human and bovine thrombins: implications in standardization and diagnostic usage.
    Fareed J; Walenga JM; Svendsen LG; Bermes EW
    Semin Thromb Hemost; 1986 Oct; 12(4):310-7. PubMed ID: 3787268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biochemical characterization of a novel fibrinolytic enzyme, PSLTro01, from a medicinal animal Porcellio scaber Latreille.
    Tian Z; Li B; Guo L; Wu M; Fu T; Cheng H; Zhu H
    Int J Biol Macromol; 2015 Sep; 80():536-46. PubMed ID: 26123818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
    Zhu H; Hoppensteadt D; Wahi R; Cunanan J; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):32-40. PubMed ID: 18977777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong activity of acid-stable trypsin inhibitor in bovine thrombin for clinical use.
    Sumi H; Hamada H; Maehara S; Mihara H
    Clin Chim Acta; 1988 Sep; 177(1):21-9. PubMed ID: 3141090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.
    Nelson PA; Powers JN; Estridge TD; Elder EA; Alea AD; Sidhu PK; Sehl LC; DeLustro FA
    J Biomed Mater Res; 2001; 58(6):710-9. PubMed ID: 11745525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starase: A bi-functional fibrinolytic protease from hepatic caeca of Asterina pectinifera displays antithrombotic potential.
    Choi JH; Sapkota K; Kim S; Kim SJ
    Biochimie; 2014 Oct; 105():45-57. PubMed ID: 24977934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the preparation of bovine alpha-thrombin.
    Workman EF; Lundblad RL
    Thromb Haemost; 1978 Feb; 39(1):193-200. PubMed ID: 580493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunogenic potentials of bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):41-9. PubMed ID: 19117966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a contaminant in thrombin in the human plasmin assay system.
    CLIFFTON EE; SIEGEL M
    J Gen Physiol; 1957 Jan; 40(3):377-92. PubMed ID: 13398570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different hypotensive responses to intravenous bovine and human thrombin preparations in swine.
    Pusateri AE; Holcomb JB; Bhattacharyya SN; Harris RA; Gomez RR; MacPhee MJ; Enriquez JI; Delgado AV; Charles NC; Hess JR
    J Trauma; 2001 Jan; 50(1):83-90. PubMed ID: 11231675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the catalytic properties of thrombin and trypsin by kinetic analysis on the basis of active enzyme concentration.
    Takasaki SI; Kasai KI; Ishii SI
    J Biochem; 1975 Dec; 78(6):1275-85. PubMed ID: 1241585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
    He Zhu ; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):273-80. PubMed ID: 20547555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.